Symbol
| HRAS
| contributors: mct/pgu - updated : 27-03-2019
|
HGNC name
| v-Ha-ras Harvey rat sarcoma viral oncogene homolog
|
HGNC id
| 5173
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| LOH
|  
|  
|
in bladder cancer and in sporadic invasive breast cancer | tumoral
| somatic mutation
|  
|  
|  
|
in dedifferentiated liposarcoma and in papillary thyroid cancer with with poor prognosis | tumoral
|  
|  
|  
| gain of function
|
mutation activating in spermatocytic seminomas | tumoral
|  
|  
| --over
|  
|
often associated with tumor aggressiveness in breast cancer | |
Variant & Polymorphism
repeat
| three GGGCCT repeats |
|
|
Candidate gene
Marker
| abnormal methylation of the HRAS gene may be an early event during urocystic tumorigenesis and may be further used as a cancer biomarker in bladder tissue for early diagnosis | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | urinary | | |
abnormal methylation of the HRAS gene may be further used as a potential therapeutic target |
| | |